News Agency
Men's Weekly

Pierre Fabre Laboratories announce granting of European marketing authorization for OBGEMSA™ (vibegron) in overactive bladder.

  • Written by PR Newswire
Pierre Fabre Laboratories announce granting of European marketing authorization for OBGEMSA™ (vibegron) in overactive bladder.

CASTRES, France, June 28, 2024 /PRNewswire/ -- The European Commission (EC) has authorized the marketing of OBGEMSA™ (vibegron) by Pierre Fabre Laboratories for the symptomatic treatment of overactive bladder syndrome in adults, a particularly debilitating condition affecting over 70 million patients* in Europe. In 2022, Pierre Fabre...

Read more: Pierre Fabre Laboratories announce granting of European marketing authorization for OBGEMSA™...

How Structured Content Improves Property Detail Pages at Scale

Property detail pages are one of the most critical components of any real estate platform. They serve as the primary decision-making environment where potential buyers or renters evaluate listings, compare options, and ultimately take action. As property portfolios grow, maintaining... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion